APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients

被引:6
|
作者
Li, Wei [1 ,2 ]
Liu, Fengju [3 ]
Liu, Rui [3 ]
Zhou, Xinmei [4 ]
Li, Guanjun [3 ]
Xiao, Shifu [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Geriat Psychiat, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Alzheimers Dis & Related Disorders Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Early Psychot Disorder, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Gen Practice, Shanghai, Peoples R China
关键词
BODY-MASS INDEX; METABOLIC SYNDROME; WEIGHT-GAIN; BIPOLAR DISORDER; SIRT1; GENE; METAANALYSIS; ALLELE; RISK; POLYMORPHISMS; PREVALENCE;
D O I
10.1038/s41598-021-94381-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity is a critical issue in patients with schizophrenia, which is considered to be brought about by both environmental and genetic factors. Apolipoprotein E (APOE) gene polymorphisms might be involved in the pathogenesis of schizophrenia, however, the effect of APOE gene polymorphism on obesity has never been investigated in Chinese aging with schizophrenia. This cross-sectional study was to investigate the effect of obesity on cognitive and psychiatric symptoms in elderly participants with schizophrenia. At the same time, we also discussed the inner link between APOE E4 and obesity. 301 elderly participants with schizophrenia and 156 normal controls were included in the study. Their cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and APOE gene polymorphism was determined by polymerase chain reaction (PCR). The prevalence of obesity in elderly schizophrenic patients and healthy controls accounted for 15.9% (48/301) and 10.3% (16/156), respectively, with no statistically significant difference. By using stepwise linear regression analysis, we found that elevated fasting blood glucose, hypertension, and hyperlipidemia were risk factors for obesity in elderly schizophrenic patients. Although there was no direct correlation between APOE E4 and obesity in patients with schizophrenia, it was significantly correlated with hyperlipemia(r=- 0.154, p=0.008), suggesting that APOE E4 may induce obesity in elderly patients with schizophrenia through hyperlipemia, However, the above conclusions do not apply to the normal elderly. What's more, we did not find a link between obesity and cognitive function or mental symptoms for both patients with schizophrenia and normal controls. APOE E4 is associated with hyperlipidemia in elderly schizophrenic patients, which may be a risk factor for obesity, however, the above conclusion does not apply to the normal elderly.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa
    Joska, John A.
    Combrinck, Marc
    Valcour, Victor G.
    Hoare, Jacqueline
    Leisegang, Felicity
    Mahne, Anna Cecilia
    Myer, Landon
    Stein, Dan J.
    JOURNAL OF NEUROVIROLOGY, 2010, 16 (05) : 377 - 383
  • [42] APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921
    Schiepers, O. J. G.
    Harris, S. E.
    Gow, A. J.
    Pattie, A.
    Brett, C. E.
    Starr, J. M.
    Deary, I. J.
    MOLECULAR PSYCHIATRY, 2012, 17 (03) : 315 - 324
  • [43] APOLIPOPROTEIN E POLYMORPHISM AND FRAILTY: APOLIPOPROTEIN E4 ALLELE IS ASSOCIATED WITH FATIGUE BUT NOT FRAILTY SYNDROME IN A COMMUNITY-DWELLING OLDER POPULATION COHORT
    Chhetri, J. K.
    Ma, L.
    Zheng, Z.
    Liu, F. -Y.
    Zhao, J.
    Gu, Z. -Q.
    Chan, P.
    JOURNAL OF NUTRITION HEALTH & AGING, 2021, 25 (04): : 410 - 415
  • [44] Peripheral blood biomarkers coupled with the Apolipoprotein E4 genotype are strongly associated with semantic and episodic memory impairments in elderly subjects with amnestic mild cognitive impairment and Alzheimer's dementia
    Supasitthumronq, Thitiporn
    Maes, Michael
    Tunvirachaisakul, Chavit
    INTERNATIONAL PSYCHOGERIATRICS, 2019, 31 : 80 - 83
  • [45] Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease
    Supasitthumrong, Thitiporn
    Tunvirachaisakul, Chavit
    Aniwattanapong, Daruj
    Tangwongchai, Sookjaroen
    Chuchuen, Phenphichcha
    Tawankanjanachot, Itthipol
    Snabboon, Thiti
    Hemrungrojn, Solaphat
    Carvalho, Andre F.
    Maes, Michael
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (03) : 797 - 811
  • [46] ApoE ε4 is not associated with posictal confusion in patients with mesial temporal lobe epilepsy with hippocampal sclerosis
    Andres Kauffman, Marcelo
    Pereira-de-Silva, Nahuel
    Consalvo, Damian
    Kochen, Silvia
    EPILEPSY RESEARCH, 2009, 85 (2-3) : 311 - 313
  • [47] Gender specific factors contributing to cognitive resilience in APOE e4 positive older adults in a population-based sample
    Zheng, Lidan
    Eramudugolla, Ranmalee
    Cherbuin, Nicolas
    Drouin, Shannon M.
    Dixon, Roger A.
    Anstey, Kaarin J.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Obesity reduces hippocampal structure and function in older African Americans with the APOE-e4 Alzheimer's disease risk allele
    Osiecka, Zuzanna
    Fausto, Bernadette A.
    Gills, Joshua L.
    Sinha, Neha
    Malin, Steven K.
    Gluck, Mark A.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [49] Urinary Leukotriene E4 Is Associated with Renal Function but Not with Endothelial Function in Type 2 Diabetes
    Rafnsson, Arnar
    Back, Magnus
    DISEASE MARKERS, 2013, 2013 : 475 - 480
  • [50] Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study
    Liew, Tau Ming
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (12): : 1664 - 1675